CD19 and B-cell chronic lymphocytic leukemia: Alternative antigenic targets other than CD19 are under investigation in CLL, such as clonal light chain (kappa or lambda), CD23, the receptor of the invariant fragment of IgM (FcγR), and ROR1 (102, 107, 185, 186).